Eric Sjogren - 23 Jan 2023 Form 4 Insider Report for Calithera Biosciences, Inc.

Role
SR. VP, DRUG DISCOVERY
Signature
/s/ Eric Sjogren
Issuer symbol
CALA on OTC
Transactions as of
23 Jan 2023
Net transactions value
-$124
Form type
4
Filing time
25 Jan 2023, 15:00:25 UTC
Previous filing
27 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CALA Common Stock Tax liability $124 -279 -3.2% $0.4461 8,467 23 Jan 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on January 23, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
F3 Includes 125 shares acquired on June 10, 2022, under the Company's 2014 Employee Stock Purchase Plan.